PMA device
eCoin Peripheral Neurostimulator
Boston Scientific Corporation · Stimulator, Tibial, Electrical, Implantable, For Urinary Incontinence (QPT, Class III) · First FDA decision Mar 1, 2022, newest Mar 3, 2026Overactive bladder and urinary incontinence
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
6
PMA pathway
Device trials
7
Naming "eCoin"
MAUDE reports
43
Brand "eCoin", since 2015
PubMed studies
13
Mentioning "eCoin"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing eCoin Peripheral Neurostimulator
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 6 decisions filed under this name.
- eCoin Peripheral NeurostimulatorPMA supplement
P200036-S010 · Decided Mar 3, 2026 · 29 days after receipt · Normal 180 Day Track No User Fee
Device type: Stimulator, tibial, electrical, implantable, for urinary incontinence (QPT) · GI, Urology & Nephrology
- eCoin Peripheral NeurostimulatorPMA supplement
P200036-S008 · Decided Jul 16, 2025 · 26 days after receipt · Normal 180 Day Track No User Fee
Device type: Stimulator, tibial, electrical, implantable, for urinary incontinence (QPT) · GI, Urology & Nephrology
- eCoin Implant Tibial StimulatorPMA supplement
P200036-S004 · Decided Nov 30, 2022 · 30 days after receipt · Normal 180 Day Track No User Fee
Device type: Stimulator, tibial, electrical, implantable, for urinary incontinence (QPT) · GI, Urology & Nephrology
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Pelvic Floor Electrical Stimulation for Urinary IncontinenceNational analysisReview closedCAG-00021NUpdated Sep 15, 2026
- Non-Implantable Pelvic Floor Electrical StimulatorNational determinationOn the books230.8Updated Aug 17, 2023
- Sacral Nerve Stimulation for Urge Urinary IncontinenceNational analysisReview closedCAG-00058NUpdated Sep 15, 2026
- Home Biofeedback For Urinary IncontinenceNational analysisReview closedCAG-00118NUpdated Sep 14, 2026
- Biofeedback for Urinary IncontinenceNational analysisReview closedCAG-00020NUpdated Sep 14, 2026
- Sacral Nerve Stimulation For Urinary IncontinenceNational determinationOn the books230.18Updated Dec 8, 2025
- Transcutaneous Electrical Nerve Stimulators (TENS) - RETIREDNational determinationOn the books280.13Updated Jun 7, 2024
- Electrical Nerve StimulatorsNational determinationOn the books160.7Updated Aug 17, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "eCoin", any status and sponsor, newest update first.
- A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)Recruiting
Valencia Technologies CorporationNot on our public-company list
NCT05685433 · 200 participants (planned) · Start Jan 26, 2023 · Primary completion Apr 2028
Device: eCoin Tibial Nerve Stimulation · For: Overactive Bladder; Urge Incontinence; Incontinence, Urinary and 1 more
Sites: Homewood, Alabama; Mobile, Alabama; Little Rock, Arkansas · 22 sites in all
Valencia Technologies CorporationNot on our public-company list
NCT05882318 · 38 participants · Start Jun 6, 2023 · Primary completion Apr 19, 2024
Device: eCoin Peripheral Neurostimulator System · For: Urge Incontinence
Sites: Downey, California; Fresno, California; Ankeny, Iowa · 7 sites in all
- Pivotal Study of eCoin for Overactive Bladder With Urgency Urinary IncontinencePivotal-lookingCompleted
Valencia Technologies CorporationNot on our public-company list
NCT03556891 · 133 participants · Start Sep 4, 2018 · Primary completion Apr 12, 2020
Device: eCoin Tibial Nerve Stimulation · For: Overactive Bladder; Urge Incontinence; Incontinence, Urinary and 1 more
Sites: Downey, California; Redwood City, California; San Diego, California · 15 sites in all
4 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "eCoin", and for the whole product code for context.
This brand
43 reports: 1 malfunction, 41 injury, 1 death
Whole product code QPT
81 reports: 2 malfunction, 77 injury, 1 death
Newest reports for this brand
Valencia Technologies Corporation
3010878085-2026-00016 · Received Sep 22, 2026 · Event dated Aug 1, 2026
Device type: Stimulator, Tibial, Electrical, Implantable, For Urinary Incontinence (QPT)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available
Valencia Technologies Corporation
3010878085-2026-00015 · Received Sep 17, 2026 · Event dated Sep 1, 2025
Device type: Stimulator, Tibial, Electrical, Implantable, For Urinary Incontinence (QPT)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available
Valencia Technologies Corporation
3010878085-2026-00014 · Received Sep 10, 2026 · Event dated Aug 13, 2026
Device type: Stimulator, Tibial, Electrical, Implantable, For Urinary Incontinence (QPT)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Eczema
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "eCoin"[tiab]. The summary above synthesizes these.
- Update on Implantable PTNS Devices.
Vollstedt A, Gilleran J · Curr Urol Rep · 2020Review
- Six-Month Outcomes of Reimplantation of a Coin-Sized Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome With Urgency Urinary Incontinence.
Kaaki B, English S, Gilling P, et al. · Female Pelvic Med Reconstr Surg · 2022
- Twelve-month Durability of a Fully-implanted, Nickel-sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence: A Single-Arm, Prospective Study.
Gilling P, Meffan P, Kaaki B, et al. · Urology · 2021Clinical Trial, Multicenter Study
- Posterior Tibial Nerve Stimulation for Overactive Bladder: Mechanism, Classification, and Management Outlines.
Al-Danakh A, Safi M, Alradhi M, et al. · Parkinsons Dis · 2022Review
- eCoin device stops patients from spending a penny.
Fenner A · Nat Rev Urol · 2019Comment
- Device evaluation: eCoin #x2013; implantable tibial nerve stimulator for overactive bladder.
Bressington MJ, Scholtz D, Hooshiary A, et al. · Expert Rev Med Devices · 2023Review
- Editorial Comment on "Two-year Pivotal Study Analysis of the Safety and Efficacy of Implantable Tibial Nerve Stimulation With eCoin® for Urgency Urinary Incontinence".
Nazim SM, Nadeem R · Urology · 2024Comment, Editorial
- Review of New Implantable Tibial Nerve Stimulators in Comparison to Established Third Line Treatment Modalities for Nonneurogenic Overactive Bladder.
Tipton WA, de Riese WTW, de Riese CS · Urol Pract · 2020
- Two-year Pivotal Study Analysis of the Safety and Efficacy of Implantable Tibial Nerve Stimulation With eCoin® for Urgency Urinary Incontinence.
Lucente V, Giusto L, MacDiarmid S · Urology · 2024Multicenter Study, Clinical Trial
- Pivotal Study of Leadless Tibial Nerve Stimulation with eCoin® for Urgency Urinary Incontinence: An Open-Label, Single Arm Trial.
Rogers A, Bragg S, Ferrante K, et al. · J Urol · 2021Clinical Trial, Multicenter Study
- Reply to Editorial Comment on "Two-year Pivotal Study Analysis of the Safety and Efficacy of Implantable Tibial Nerve Stimulation With eCoin® for Urgency Urinary Incontinence".
Lucente V · Urology · 2024Comment, Letter
- Feasibility of a Fully Implanted, Nickel Sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence.
MacDiarmid S, Staskin DR, Lucente V, et al. · J Urol · 2019Clinical Trial, Multicenter Study
Other devices of this type
Also filed under product code QPT.
- AltavivaMedtronic Neuromodulation · PMA 2026
- Medtronic Altaviva SystemMedtronic Neuromodulation · PMA 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.